Skip to Content

Significant Updates on Neoadjuvant Treatments for Stage 3 Melanoma

Marco Donia moderated a press conference on immunotherapy at ESMO 2024. In this MEDtalk, he discusses significant updates on neoadjuvant treatments for stage 3 melanoma, where immunotherapy before surgery improves outcomes, mainly when a significant pathological response is achieved.

Marco Donia

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top